Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Brembilla

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
European Urology Focus|October 21, 2023
Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS ScoreFrancesco Pellegrino, Armando Stabile, Gabriele Sorce, et al.
Urologic Oncology|April 21, 2024
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancerFrancesco Cei, Alessandro Larcher, Giuseppe Rosiello, et al.
European Radiology|February 14, 2020
Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1Giorgio Brembilla, Paolo Dell'Oglio, Armando Stabile, et al.
BJU International|January 26, 2026
The 'Comparison of diagnostic accuracy of Luminal Index and standard of care MRI for Accelerated deTEction of prostate cancer' (CLIMATE) trial protocolTarek Al-Hammouri, Giorgio Brembilla, Mrishta Brizmohun, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|April 30, 2026
PRECISE Version 2: Essential Tips for Prostate Cancer Monitoring Using MRIArthur Ogata, Giorgio Brembilla, Adriano B Dias, et al.
European Urology|February 3, 2026
Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder CancerValentina Tateo, Giuseppe Basile, Patrizia Giannatempo, et al.
Urologic Oncology|April 18, 2021
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era?Elio Mazzone, Armando Stabile, Gabriele Sorce, et al.
BJU International|October 13, 2025
Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy historyDonato Cannoletta, Armando Stabile, Leonardo Quarta, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 18, 2023
Role of [<sup>68</sup>Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancerSamuele Ghezzo, Paola Mapelli, Carolina Bezzi, et al.
European Urology Open Science|January 19, 2026
Real-world Inter-rater Agreement of PI-QUAL Version 2 for Prostate Magnetic Resonance Imaging Quality Assessment and Its Association with Diagnostic AccuracyDaniel L van den Kroonenberg, Jelle Barentsz, Bo J Hamstra, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
European Urology Focus|October 21, 2023
Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS ScoreFrancesco Pellegrino, Armando Stabile, Gabriele Sorce, et al.
Urologic Oncology|April 21, 2024
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancerFrancesco Cei, Alessandro Larcher, Giuseppe Rosiello, et al.
European Radiology|February 14, 2020
Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1Giorgio Brembilla, Paolo Dell'Oglio, Armando Stabile, et al.
BJU International|January 26, 2026
The 'Comparison of diagnostic accuracy of Luminal Index and standard of care MRI for Accelerated deTEction of prostate cancer' (CLIMATE) trial protocolTarek Al-Hammouri, Giorgio Brembilla, Mrishta Brizmohun, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|April 30, 2026
PRECISE Version 2: Essential Tips for Prostate Cancer Monitoring Using MRIArthur Ogata, Giorgio Brembilla, Adriano B Dias, et al.
European Urology|February 3, 2026
Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder CancerValentina Tateo, Giuseppe Basile, Patrizia Giannatempo, et al.
Urologic Oncology|April 18, 2021
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era?Elio Mazzone, Armando Stabile, Gabriele Sorce, et al.
BJU International|October 13, 2025
Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy historyDonato Cannoletta, Armando Stabile, Leonardo Quarta, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 18, 2023
Role of [<sup>68</sup>Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancerSamuele Ghezzo, Paola Mapelli, Carolina Bezzi, et al.
European Urology Open Science|January 19, 2026
Real-world Inter-rater Agreement of PI-QUAL Version 2 for Prostate Magnetic Resonance Imaging Quality Assessment and Its Association with Diagnostic AccuracyDaniel L van den Kroonenberg, Jelle Barentsz, Bo J Hamstra, et al.
Pageof 7